United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-868_3a214bf4-ea51-0892-e063-6394a90a9a9d
- Product NDC
- 43063-868
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130401
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 TABLET in 1 BOTTLE, PLASTIC (43063-868-12) · 43063-868-12
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-868-30) · 43063-868-30
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-868-60) · 43063-868-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →